87 related articles for article (PubMed ID: 31836602)
21. Incidence of cervical cytological abnormalities following a negative smear result in an opportunistic screening scenario: A cohort study.
Pinho-França JR; Costa Chein MBD; Thuler LCS
Eur J Obstet Gynecol Reprod Biol; 2019 Nov; 242():103-108. PubMed ID: 31580961
[TBL] [Abstract][Full Text] [Related]
22. Quality of screening with conventional Pap smear in Austria - a longitudinal evaluation.
Rásky É; Regitnig P; Schenouda M; Burkert N; Freidl W
BMC Public Health; 2013 Oct; 13():998. PubMed ID: 24152300
[TBL] [Abstract][Full Text] [Related]
23. Variations in Progression and Regression of Precancerous Lesions of the Uterine Cervix on Cytology Testing Among Women of Different Races.
Martingano D; Renson A; Martingano AJ; Martingano FX
J Am Osteopath Assoc; 2018 Jan; 118(1):8-18. PubMed ID: 29309102
[TBL] [Abstract][Full Text] [Related]
24. [Cervical cancer screening in the State of Maranhão, Brazil].
Silva DS; Silva AM; Brito LM; Gomes SR; Nascimento Mdo D; Chein MB
Cien Saude Colet; 2014 Apr; 19(4):1163-70. PubMed ID: 24820599
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of uterine cervical cancer in pregnancy: A cross-sectional study.
Vasques RB; Carramenha LL; Basílio I; Leão MEB; Carvalho GPSL; Amaral RMC; Rezende-Filho J; Guerra Neto NGM; Furtado YL
Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():35-39. PubMed ID: 31927408
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
[TBL] [Abstract][Full Text] [Related]
27. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
Misra JS; Srivastava AN; Gupta HP
Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
[TBL] [Abstract][Full Text] [Related]
28. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
Al Rifai R; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
[TBL] [Abstract][Full Text] [Related]
29. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
[TBL] [Abstract][Full Text] [Related]
30. Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey.
Nayir T; Okyay RA; Nazlican E; Yesilyurt H; Akbaba M; Ilhan B; Kemik A
Asian Pac J Cancer Prev; 2015; 16(16):6909-12. PubMed ID: 26514466
[TBL] [Abstract][Full Text] [Related]
31. MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears.
Matheus ER; Zonta MA; Discacciati MG; Paruci P; Velame F; Cardeal LB; Barros SB; Pignatari AC; Maria-Engler SS
Diagn Cytopathol; 2014 Oct; 42(10):827-33. PubMed ID: 24578283
[TBL] [Abstract][Full Text] [Related]
32. How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case.
Chocontá-Piraquive LA; Alvis-Guzman N; De la Hoz-Restrepo F
BMC Health Serv Res; 2010 Sep; 10():270. PubMed ID: 20846446
[TBL] [Abstract][Full Text] [Related]
33. Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach.
Dhanasekaran K; Verma C; Kumar V; Hariprasad R; Gupta R; Gupta S; Mehrotra R
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1265-1269. PubMed ID: 31030504
[TBL] [Abstract][Full Text] [Related]
34. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
36. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
Tavasoli SM; Kane E; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
38. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
39. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
Shlay JC; McGill WL; Masloboeva HA; Douglas JM
Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
[TBL] [Abstract][Full Text] [Related]
40. Age Specific Cytological Abnormalities in Women Screened for Cervical Cancer in the Emirate of Abu Dhabi.
Al Zaabi M; Al Muqbali S; Al Sayadi T; Al Ameeri S; Coetsee K; Balayah Z; Ortashi O
Asian Pac J Cancer Prev; 2015; 16(15):6375-9. PubMed ID: 26434845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
